ArticleBriefings in bioinformatics2026
MCOD: a memory-constrained deep learning framework for robust outlier detection in quantitative proteomics.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Ensuring robust quality control (QC) remains a major challenge in quantitative proteomics, particularly in detecting and managing outliers. Deep learning offers powerful representational capacity for ultra-high-dimensional data but often suffers from overfitting in small-sample scenarios. To address this, we propose memory-constrained outlier detection (MCOD), a deep anomaly detection framework that directly processes MaxQuant outputs and achieves competitive recall at high precision levels, which suggests a reduced risk of overlooking true outliers. MCOD integrates two innovations: (i) a memory-constrained module (MC module) that mitigates over-representation of samples via prototype-based regularization, and (ii) an adaptive steady-aware regulator that dynamically adjusts the per-sample loss weights in the MC module according to the estimated overfitting risk. Across two simulation settings based on a human cervical cancer cell line (HeLa) proteomics dataset and two real-world cancer proteomics datasets, MCOD consistently outperformed 18 statistical, machine learning, and deep learning baselines, achieving superior area under the receiver operating characteristic curve and area under the precision-recall curve scores. Functional enrichment analyses on the two real-world datasets showed that MCOD performed favorably compared to the three domain-specific models. Furthermore, feature-level visualization provided insights into the rationale behind the model's anomaly assignments. Collectively, MCOD establishes a robust and scalable framework for data QC in quantitative proteomics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.